GlassScriptPhysician profile
James K Russo
NPI 1376700591
$20,095.83
in general payments reported to CMS, 2019-2025
28 companies · $700 in 2025
The $700 reported for 2025 was more than what 79% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $751 · 2020: $265 · 2021: $960 · 2022: $3,957 · 2023: $6,497 · 2024: $6,966 · 2025: $700.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Food and Beverage: $2,698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,465.00 |
| Food and Beverage | $2,697.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $9,020.22 | 2022-2024 | Pylarify |
| Dendreon Pharmaceuticals LLC | $6,465.73 | 2020-2025 | Provenge |
| Pfizer INC. | $620.16 | 2021-2025 | |
| Brainlab, INC. | $543.65 | 2019 | |
| Astellas Pharma US INC | $508.40 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $489.16 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $266.35 | 2023-2025 | Orgovyx, Gemtesa |
| Novartis Pharmaceuticals Corporation | $263.43 | 2021-2025 | |
| Janssen Biotech, INC. | $243.32 | 2019-2025 | Erleada |
| Bioprotect Medical, INC. | $233.03 | 2024-2025 | Bioprotect Balloon Implant System |
| Myovant Sciences INC. | $191.28 | 2021-2022 | |
| Medtronic USA, INC. | $162.02 | 2019 | |
| Boston Scientific Corporation | $139.79 | 2020-2023 | |
| Myriad Genetic Laboratories, INC. | $139.29 | 2020-2023 | Prolaris |
| Teleflex LLC | $133.33 | 2024 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accord Healthcare, INC. | $129.47 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $92.45 | 2022-2025 | Lynparza |
| Blue Earth Diagnostics | $90.63 | 2020-2024 | |
| Amgen INC. | $82.36 | 2021-2022 | |
| Novocure INC. | $67.72 | 2024-2025 | Optune Gio, Optune |
| Merck Sharp & Dohme LLC | $55.39 | 2022-2025 | Keytruda |
| Sun Pharmaceutical Industries INC. | $36.24 | 2021 | |
| Siemens Medical Solutions USA, INC. | $32.15 | 2023 | Varian Identify, Truebeam |
| Springworks Therapeutics, INC. | $21.10 | 2025 | Ogsiveo |
| Palette Life Sciences, INC. | $20.23 | 2022 | |
| Axonics, INC. | $17.99 | 2021 | |
| Endo USA, INC. | $17.27 | 2025 | Xiaflex |
| Telix Pharmaceuticals | $13.67 | 2023 | Illuccix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Russo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.